Results 81 to 90 of about 24,950 (282)
Acta Dermato-Venereologica, 2019 Treatment of male androgenetic alopecia with 5α-reductase inhibitors is efficacious. However, the risk of adverse sexual effects remains controversial.
Solam Lee +3 more
semanticscholar +1 more source
Topical Finasteride in Hirsutism: A Double Blind Randomized Clinical Trial on Adult Women
Journal of Research in Medical Sciences, 2005 Background: Finasteride partially blocks the conversion of testosterone to dihydrotestosterone through inhibition of 5 α- reductase in hair follicles. Finasteride cream can penetrate to dermis to arrive at hair follicle due to its solubility.
F Iraji, S Karbasioun, A Aminorroaya
doaj
Cognitive effects of testosterone and finasteride administration in older hypogonadal men
, 2014 Stephen E Borst,1 Joshua F Yarrow,2 Carmen Fernandez,1 Christine F Conover,2 Fan Ye,2 John R Meuleman,1 Matthew Morrow,3 Baiming Zou,4 Jonathan J Shuster5 1Geriatric Research, Education and Clinical Center, 2Research Service, 3Pharmacy Service, Malcom ...
Yarrow JF +8 more
core
Journal of Cosmetic Dermatology, Volume 25, Issue 6, June 2026.ABSTRACT Background Androgenetic alopecia (AGA), the most common form of progressive hair loss in men, significantly impairs both physical and psychological well‐being. While traditional research has predominantly focused on cellular components and signaling pathways, the extracellular matrix (ECM)—particularly collagen—is increasingly recognized as ...
Meitong Jin +7 more
wiley +1 more source
Association of finasteride with prostate cancer
Medicine, 2020 Background: The Prostate Cancer Prevention Trial has shown a protective effect of finasteride on prostate cancer, but it also showed that finasteride can increase the risk of high-grade prostate cancer.
Lei Wang +9 more
semanticscholar +1 more source
, 2015 Osama O Elkelany, Ryan C Owen, Edward D KimDepartment of Surgery, Division of Urology, University of Tennessee Graduate School of Medicine, Knoxville, TN, USAAbstract: The evidence suggests that combination therapy for benign prostatic hyperplasia (BPH ...
Elkelany OO, Kim ED, Owen RC
core
Bedside risk score for medical therapy failure in small‐volume BPH: Temporal validation
BJUI Compass, Volume 7, Issue 5, May 2026.Abstract Purpose Medical therapy is the first‐line treatment for lower urinary tract symptoms (LUTS) secondary to benign prostatic hyperplasia (BPH). However, predictors of treatment failure in men with small prostate volume (<30 ml) remain poorly defined.
Numan Alam +8 more
wiley +1 more source
FINASTERIDE-ASSOCIATED MALE INFERTILITY
, 2004 Finasteride is a potent and specific inhibitor of the 5α-reductase enzyme in men. Clinical studies have shown that finasteride 1mg/day is effective for promoting hair growth in men with male pattern hair loss. However, there is a concern about the use of
Saade, Ricardo +12 more
core
Health Science Reports, Volume 9, Issue 5, May 2026.ABSTRACT Background Nanotechnology has emerged as a transformative approach in dermatology, offering potential for enhanced drug delivery, targeted therapy, and improved bioavailability for various skin conditions. However, despite significant research output, translational barriers persist due to heterogeneous study designs, safety concerns, and ...
Mohammed Saleh Al‐Dhubaibi +5 more
wiley +1 more source
International Journal of Dermatology, Volume 65, Issue 7, Page 1477-1479, July 2026.
Samantha Bestavros +2 more
wiley +1 more source